PROFESSIONAL EDITION

The largest community of pharma leaders

Look Who’s On the Move!

      ImmuneID Appoints Veteran Biotech Executive James S. Scibetta as CEO

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, today...

      Gossamer Bio Announces Appointment of Bryan Giraudo as Chief Operating Officer, in addition to Chief Financial Officer Role

      SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of...

      MPM Expands its Team with the Appointment of RNA Expert and Leading Biotech Executive Pete Smith, PhD

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--MPM, a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in early-stage therapeutics companies, today announced the...

      Life Sciences BC Board of Directors Announcement

      VANCOUVER, British Columbia--(BUSINESS WIRE)--Following a well-attended AGM, Life Sciences BC is pleased to announce new Board of Directors members, with thanks to those who...

      Sonoma Biotherapeutics Expands Leadership Team with the Appointment of Doug Sheehy, J.D., as Chief Legal Officer and Secretary

      SOUTH SAN FRANCISCO, Calif. & SEATTLE--(BUSINESS WIRE)--Sonoma Biotherapeutics, an immune tolerance company focused on the development of regulatory T cell (Treg) therapies, today announced...

      Alzheon Appoints Adem Albayrak as Head of Operations and Earvin Liang, PhD, as Vice President of Clinical Development

      FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer’s disease...

      Recent Articles